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Introduction: The aims of these studies were to identify the cytokine and chemokine expression profile of nucleus
pulposus (NP) cells and to determine the relationships between NP cell cytokine and chemokine production and
the characteristic tissue changes seen during intervertebral disc (IVD) degeneration.
Methods: Real-time q-PCR cDNA Low Density Array (LDA) was used to investigate the expression of 91 cytokine
and chemokine associated genes in NP cells from degenerate human IVDs. Further real-time q-PCR was used to
investigate 30 selected cytokine and chemokine associated genes in NP cells from non-degenerate and degenerate
IVDs and those from IVDs with immune cell infiltrates (‘infiltrated’). Immunohistochemistry (IHC) was performed for
four selected cytokines and chemokines to confirm and localize protein expression in human NP tissue samples.
Results: LDA identified the expression of numerous cytokine and chemokine associated genes including 15 novel
cytokines and chemokines. Further q-PCR gene expression studies identified differential expression patterns in NP
cells derived from non-degenerate, degenerate and infiltrated IVDs. IHC confirmed NP cells as a source of IL-16,
CCL2, CCL7 and CXCL8 and that protein expression of CCL2, CCL7 and CXCL8 increases concordant with
histological degenerative tissue changes.
Conclusions: Our data indicates that NP cells are a source of cytokines and chemokines within the IVD and that
these expression patterns are altered in IVD pathology. These findings may be important for the correct assessment
of the ‘degenerate niche’ prior to autologous or allogeneic cell transplantation for biological therapy of the
degenerate IVD.Introduction
Intervertebral discs (IVDs) are amphiarthroses that func-
tion to permit flexion, extension and lateral bending of
the spine. IVDs comprise three distinct tissue regions;
the endplates, the annulus fibrosus (AF) and the nucleus
pulposus (NP). The NP is the central gelatinous region
and consists of a sparse cell population [1] within a
complex hydrated extracellular matrix (ECM) of collagen
fibres and hydrophilic proteoglycans [2]. The NP is* Correspondence: c.lemaitre@shu.ac.uk
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reproduction in any medium, provided the orconstrained around the periphery by the fibrous concen-
tric lamella of the AF, and above and below by the end-
plates and the vertebral bodies that each IVD separates.
IVD degeneration is a non-inflammatory arthropathy;
as such, the detrimental tissue remodelling events that
occur result from alterations in the behaviour of the
native cell population. During degeneration, the NP is
the site of specific characteristic tissue changes whereby
the hydrated gelatinous ECM is condensed and replaced
by a more fibrous structure [3]. These structural changes
compromise the biomechanics of the IVD, and can lead
to prolapse [4].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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occur in respect of proliferation [5], differentiation [6-8],
dysregulated metabolism [3,9] and cell death [10,11]. Cy-
tokines are implicated as stimulus for the characteristic
alterations in cell behaviour. IL-1 and TNF-α are pro-
duced within the IVD, and expression levels are increased
in degeneration [12-16]. Further, it is reported that in vitro
IL-1 or TNF-α stimulation disrupts cellular metabolism in
a similar manner to that seen in IVD degeneration
[15,17-19]. However, in IVD prolapse, which can occur
independently (as a result of exceeding the physiological
limit of flexion or compressive force through a motion
segment [20,21], or as a secondary complication of IVD
degeneration [22], locally produced cytokines may form
part of the mechanism of spontaneous resorption. The
spontaneous resorption of prolapsed lumbar IVD tissue
has frequently been observed [23-25] although the exact
mechanisms by which this occur are not yet fully under-
stood. Inflammatory and autoimmune responses provoked
in the innate and adaptive immune systems on detection
of displaced tissue likely play a role, with infiltrating
monocytes [26], macrophages [26-29], T and B lym-
phocytes [27,28] and fibroblasts [29] reported in prolapsed
NP tissue.
To understand the pathogenesis of degeneration, it is
important to determine the factors present within the IVD
that may elicit behavioural effects on the cells present.
Currently, several research initiatives are investigating
the regenerative potential of autologous or allogeneic cell
transplantation, and mesenchymal or adipose-derived
stem-cell transfer to enhance the degenerate native cell
population [30-35]. To this end, an understanding of the
micro-environmental conditions of the degenerate niche
would provide indication as to the factors that may act
upon cells, native or introduced, to such an environment.
Expression of several cytokines and chemokines (chemo-
attractant cytokines) have been identified within the IVD
[14,26,36-38], although, with the exception of IL-1 and
TNF-α, the cellular source and biological activities of
these factors has not been well studied [12,15]. In these
investigations, we address the hypothesis that cytokines
and chemokines are integral to the pathogenesis of IVD
degeneration and prolapse. Specifically, we aimed to iden-
tify the cytokine and chemokine expression profile of NP
cells and the relationships between cytokine and chemo-
kine production, and the characteristic tissue changes seen
during IVD degeneration.
Methods
Human IVD tissue samples
Fifty human lumbar IVD tissue samples were obtained
for use in this study, either at surgery or post-mortem
examination (PM) with informed consent of the patient
or relatives (Table 1). Local ethics approval was givenfor this work by Sheffield Research Ethics Committee
(09/H1308/70).
PM tissue
Eight IVDs were recovered from two donors with no re-
corded history of IVD disease or low back pain. They
consisted of whole IVDs from which full-thickness
wedges of 120° of arc were removed anteriorly for pro-
cessing to paraffin wax. Remaining NP tissue was
washed in sterile phosphate-buffered saline and placed
for NP cell isolation.
Surgical tissue
Forty-two NP samples were recovered from patients
undergoing microdiscectomy surgery for alleviation of
root pain related to IVD prolapse at Northern General
Hospital, Sheffield, UK. Surgical samples consisted of
multiple fragments of NP tissue with some samples con-
taining fragments of NP with AF or cartilaginous end-
plate (CEP) attached. All surgical samples were assessed
macroscopically upon receipt at the processing labora-
tory; where possible, one large fragment of NP only was
divided into two, with one half being processed to paraf-
fin wax and the other half placed for cell isolation; any
remaining smaller fragments were also processed to par-
affin wax. Samples containing multiple small NP frag-
ments or a mixture of small and large NP fragments
where the large fragments had AF or CEP attached were
processed in their entirety to paraffin wax.
Processing to paraffin wax, routine histology and
immunohistochemistry for sample grading
Tissue samples were fixed in 10% neutral buffered forma-
lin (Leica, Milton Keynes, UK) and processed to paraffin
wax on a Shandon Elliott Duplex Processor. Haematoxylin
and eosin stained sections were evaluated independently
by two researchers (KLEP and CLLM) to determine
the extent of degenerative tissue changes. Sections were
scored numerically between 0 and 12 based on the pre-
sence of cell clusters, fissures, loss of demarcation and hae-
matoxophilia (indicating reduced proteoglycan content);
a score of 0 to 3 indicates a histologically normal (non-
degenerate) IVD and a grade ≥4 indicates evidence of
degeneration, as described previously [15]. Inter-observer
scores were averaged and assigned to each tissue sample.
Sections were also taken for routine immunohistochemical
(IHC) analysis of CD11b expression. CD11b is a leukocyte
adhesion molecule and was used to identify immune cell
infiltrates in NP tissue samples from prolapsed IVDs.
CD11b IHC analysis was performed as described in the
IHC method below, using a rabbit polyclonal primary anti-
body (1:50). Samples were classified as infiltrated on the
basis of CD11b immunopositivity.
Table 1 Tissue donor and sample classification details
Donor details Sample classification
Ref. Source Age (y) Level Intact cDNA IL-16 IHC CCL2 IHC CCL7 IHC CXCL8 IHC
1 S 42 L4/L5 No I 4.0* 4.0* 4.2* 4.0*
2 S 40 L5/S1 Yes I 7.3* 7.3* 5.7* 7.3*
3 S 25 L4/L5 Yes D 4 4 4.7 4
4 S 48 L4/L5 Yes NA 4.0* 4.0* 5.7* 4.0*
5 S 33 L5/S1 Yes D NA NA NA NA
6 S NA NA NA NA 6.0* 6.0* 7.0* 6.0*
7 S 62 L4/L5 Yes NA 7.5 7.5 7.3 7.5
8 S 32 L5/S1 Yes N 2.3 2.3 3 2.3
9 S 26 L5/S1 Yes NA NA 3.3 NA 3.3
10 S 53 L4/L5 No NA 7.5* 7.5* 7.5* 7.5*
11 S 40 L5/S1 Yes NA 7.4 7.4 5.5 7.4
12 S 66 L5/S1 NA NA 5.7* 5.7* 5.5* 5.7*
13 S 34 L4/L5 Yes NA 6.2 6.2 7.5 6.2
14 S NA NA Yes D NA NA NA NA
15 S 45 L5/S1 Yes D NA NA NA NA
16 S 26 L4/L5 Yes I NA NA NA NA
17 S 23 L4/L5 Yes N NA NA NA NA
18 S 29 L4/L5 Yes I NA NA NA NA
19 S 35 L5/S1 No N NA NA NA NA
20 S 20 L4/L5 No I NA NA NA NA
21 S 39 L5/S1 No I NA NA NA NA
22 PM 45 L4/L5 Yes N 1.8 1.8 2 1.8
23 PM 45 L3/L4 Yes N 3 3 2.5 3
24 PM 45 L5/S1 Yes NA 3.5 3.5 3.5 3.5
25 S 48 L4/L5 No D 9.5 9.5 6 9.5
26 S 26 L5/S1 No D 11 11 3.5 11
27 S 33 L5/S1 Yes I 8.5* 8.5* 6.5* 8.5*
28 PM NA L1/L2 Yes NA 10 10 6 10
29 PM NA L4/L5 Yes NA 8 8 6 8
30 PM NA L5/S1 Yes NA 7 7 9 7
31 PM NA L3/L4 Yes NA 8 8 7.3 8
32 PM NA L2/L3 Yes NA 11 11 10.3 11
33 S 42 L5/S1 Yes N NA NA NA NA
34 S 36 L5/S1 Yes D 8 8 4 8
35 S 41 L5/S1 Yes D 7.5 NA 7.5 NA
36 S NA NA NA I 6.0* 6.0* 4.7* 6.0*
37 S 44 L5/S1 Yes I 3.0* 3.0* 2.3* 3.0*
38 S 52 L4/L5 Yes D 10.5 10.5 7 10.5
39 S NA L4/L5 No I 9.0* 9.0* 6.2* 9.0*
40 S 38 L5/S1 No I 5.8* 5.8* 5.2* 5.8*
41 S 28 L4/L5 Yes D 7.7 7.7 3.5 7.7
42 S 43 L5/S1 No D NA NA NA NA
43 S 44 L5/S1 Yes D NA NA NA NA
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Table 1 Tissue donor and sample classification details (Continued)
44 S 28 L5/S1 No D NA NA NA NA
45 S 35 L5/S1 Yes D NA NA NA NA
46 S 43 L5/S1 No D NA NA NA NA
47 S 42 L5/S1 No D NA NA NA NA
48 S 62 L3/L4 Yes I NA NA NA NA
49 S 40 L3/L4 Yes D NA NA NA NA
50 S 45 L4/L5 No I NA NA NA NA
S, surgical; PM, post-mortem; I, infiltrated; D, degenerate; N, non-degenerate, IHC, immunohistochemistry; CCL, C-X-C chemokine. Surgically obtained prolapsed tissue
samples were considered to be from intact IVDs when no signs of annulus fibrosus or cartilaginous endplate rupture were evident (protrusion-type prolapse).
Values given for IHC sample classification are average histologically determined grades of degeneration; *infiltrating immune cells were observed; NA, not applicable.
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On account of the heterogeneity often observed in pro-
lapsed IVD tissues [39], serial sections were made from
paraffin-embedded tissues that had matched cDNA sam-
ples derived from surgically obtained NP. Routine histo-
logical and IHC examinations were made on multiple
sections, at different levels throughout the paraffin-embed-
ded tissue, to ensure assessment of any heterogeneity.
cDNA samples were only considered to be from non-de-
generate tissue if all haematoxylin and eosin stained sec-
tions were assigned a histological grade of degeneration <4.
cDNA samples were considered to be from an infiltrated
IVD if CD11b immunopositivity (indicating leukocyte pre-
sence) was observed in any tissue section evaluated.
Grade assignment for immunohistochemistry samples
For each tissue section used in IHC evaluation, routine
histology was performed on an adjacent serial section.
By this method, the grade of degeneration assigned is
relevant to the tissue assessed by IHC even in surgically
obtained tissue samples where heterogeneity is some-
times observed.
Cell isolation and generation of cDNA samples
NP tissue samples were finely minced and digested with
2 U/ml protease (Sigma, Poole, UK) in DMEM (Gibco,
Paisley, UK) for 30 minutes at 37°C, followed by 2 mg/mL
collagenase type I (Sigma) in DMEM for 4 hours at 37°C.
Cells were recovered by centrifugation and RNA ex-
tracted immediately from 1 × 105 cells using tri-reagent
(Invitrogen, Paisley, UK). Genomic DNA contamination
was eliminated by DNase treatment (Qiagen, Crawley,
UK) prior to RNA purification by MinElute Cleanup kit
(Qiagen) as per manufacturer's protocol. cDNA was
reverse transcribed using Moloney Murine Leukaemia
Virus reverse transcriptase (Bioline, London, UK) and ran-
dom hexamers (Applied Biosystems, Warrington, UK).
CDNA low density array
In total, six cDNA samples were interrogated by real-
time PCR low density array (LDA; Applied Biosystems)for the expression of 91 cytokine- and chemokine-
associated genes. Three cDNA samples were selected
from each of two study groups; non-degenerate (mean
age 34 years, range 25 to 45) and degenerate (mean age
32 years, range 29 to 33), according to routine histo-
logical examination of matched paraffin-embedded tis-
sues. Briefly, a mastermix was prepared for each sample
and 20 μL per well loaded onto 96-well FAST® LDA
plates - equivalent to 2 μL cDNA, 10 μL Taqman® FAST®
universal mastermix (Applied Biosystems) and 8 μL sterile
deionised water per well. Plates were run on a StepOnePlus
real-time PCR machine (Applied Biosystems) on a FAST®
programme incorporating 50 cycles of denaturation at
95°C for 1 second followed by annealing and extension at
60°C for 20 seconds. Measurements were performed in
duplicate, averaged and normalised to expression of five
internal reference genes. Full details of LDA plate design
are available online (see Additional file 1). Following ana-
lysis of cDNA, LDA data-targets were selected for further
investigation by real-time PCR and IHC (Figure 1).
Real-time PCR
Following LDA analysis 30 cytokine- and chemokine-
associated genes were selected for further investigation by
real-time q-PCR. In total, 35 cDNA samples (Table 1)
were divided into three study groups; non-degenerate,
degenerate and infiltrated according to routine histological
and IHC examination of matched paraffin-embedded tis-
sues, and subjected to gene expression analysis. Briefly, a
mastermix was prepared for each target gene investigated
and 8 μL per well loaded onto 96-well FAST® PCR plates -
equivalent to 5 μL Taqman® FAST® universal mastermix
(Applied Biosystems), 2.5 μL sterile deionised water and 0.5
μL Taqman® gene expression assay (Applied Biosystems)
per well, alongside 2 μL sample cDNA. Plates were run
on a StepOnePlus real-time PCR machine as described
above. Measurements were performed in duplicate,
averaged and normalised to expression of two internal
reference genes (GAPDH and 18S). Full details of Taqman®
gene expression assays used are available online (see
Additional file 1).
Figure 1 Study outline and experimental approaches. Initial low density array (LDA) analysis of cells isolated from human nucleus pulposus
(NP) tissue samples identified a diverse cytokine and chemokine expression profile. From these data, 30 targets were selected for further gene
expression analysis by real-time qPCR and 4 targets were selected for protein production and localisation analysis by immunohistochemistry.
Consideration was given to the frequency at which targets were detected and any differential expression profile observed between non-degenerate
and degenerate study groups to select targets for further investigation. Consideration was also given to the detection of receptor mRNA expression
(indicating potential for autocrine or paracrine signalling involvement), whether the roles of identified targets had previously been well studied, the
identification of novel targets within the intervertebral disc, and links to cytokine and chemokine activity in other arthropathies.
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Four chemokines were selected for IHC investigation of
protein production and localisation following LDA ana-
lysis of gene expression. Expression of each target chemo-
kine was investigated in 30 IVD tissue samples (Table 1),
divided between three study groups; non-degenerate,
degenerate and infiltrated, according to routine his-
tological and IHC examination. Briefly, 4-μm paraffin
sections were de-waxed, rehydrated and endogenous per-
oxidase-blocked using hydrogen peroxide. After washing
in tris-buffered saline (TBS; 20 mM tris, 150 mM sodium
chloride, pH 7.5), sections were subjected to heat-induced
antigen retrieval (10-minute microwave irradiation in
0.05 M tris buffer, pH 9.5). Following TBS washing, non-
specific binding sites were blocked at room tempera-
ture for 90 minutes with 25% w/v goat serum (Abcam,
Cambridge, UK) in 1% w/v bovine serum albumin in TBS.
Sections were incubated overnight at 4°C with rabbit poly-
clonal primary antibodies against human IL-16 (1:750),
CCL2 (1:500), CCL7 (1:10,000) and CXCL8 (1:100). Nega-
tive controls in which rabbit IgGs (Abcam) replaced the
primary antibody at an equal protein concentration
were used. After washing in TBS, sections were incu-
bated in biotinylated goat anti-rabbit antiserum (1:500;
Abcam) for 30 minutes at room temperature. Disclosure
of secondary antibody binding was by the streptavidin-
biotin complex (Vector Laboratories, Peterborough,
UK) technique with 0.08% v/v hydrogen peroxide in
0.65 mg/mL 3,3'-diaminobenzidine tetrahydrochloride
(Sigma) in TBS. Sections were counterstained withMayer’s Haematoxylin (Leica), dehydrated, cleared and
mounted in Pertex (Leica).
All slides were visualised using an Olympus BX60 micro-
scope and images captured using a digital camera and soft-
ware program QCapture Pro v8.0 (MediaCybernetics,
Marlow, UK). Evaluation of IHC staining was performed
by counting 200 NP cells, with immunopositive cells ex-
pressed as a percentage of total count. A polarizing filter
was used during slide evaluation to ensure cells counted
were within NP tissue only, as any AF fragments can be
identified by differential collagen-fibre arrangement visible
under polarized light. Since the majority of samples col-
lected for use in this study consisted of NP tissue only, no
attempt was made to quantify immunopositivity in AF or
CEP IVD regions.
Statistical analysis
Statistical analysis of LDA and q-PCR data was per-
formed against two parameters; where mRNA expres-
sion was detected, the Mann-Whitney test (for LDA) or
Kruskal-Wallis combined with the Conover-Inman post
hoc test (for q-PCR) was used to investigate significant
differences in expression level between study groups;
when the frequency at which expression was detected
was not equivalent between study groups, the two-
sample test of proportionality was used to investigate
significant differences in detection frequency. Statistical
analysis of IHC data was performed against two parame-
ters; the Kruskal-Wallis test was used to investigate sig-
nificant differences in expression level between study
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tigate correlations between measured protein expres-
sion and the extent of degenerative tissue changes.
Results
A diverse cytokine and chemokine mRNA expression
profile was identified in total cells isolated from human
NP tissue specimens
cDNA LDA was performed to assess the diversity and ex-
tent of cytokine- and chemokin-associated gene expressionFigure 2 cDNA low density array cytokine and chemokine expression
was detected in nucleus pulposus cells; 15 of the identified cytokines and
intervertebral disc (IVD). Comparative analysis indicates expression of 16 tar
frequency of mRNA detection in NP cells derived from non-degenerate IVD
analysis performed on this target; P, further protein expression analysis perby cells isolated from NP tissue. An extensive gene expres-
sion profile was detected, including 15 cytokines and che-
mokines not previously identified within the IVD; IL-11,
IL-16, IL-18, IL-23, TNF-β, OSM, LIF, CCL8, CCL19,
CCL20, CXCL2, CXCL3, CXCL5, CXCL6 and CX3CL1
(Figures 2 and 3). Expression of numerous receptor and
signalling accessory molecules was also identified. Com-
parative analysis of data generated from non-degenerate
and degenerate samples suggests that 16 of the identified
cytokines and chemokines: IL-1β, IL-6, IL-10, IL-11,profile of NP cells. Gene expression of 36 cytokines and chemokines
chemokines have not been identified previously within the
gets is increased in NP cells derived from degenerate IVDs. ^Increased
s compared to degenerate (P <0.05); G, further gene expression
formed on this target.
Figure 3 cDNA low density array LDA cytokine and chemokine expression profile of nucleus pulposus (NP) cells. Gene expression of
36 cytokines and chemokines was detected in NP cells; 15 of the identified cytokines and chemokines have not been identified previously within
the intervertebral disc (IVD). Comparative analysis indicates expression of 16 targets is increased in NP cells derived from degenerate IVDs.
^Increased frequency of mRNA detection in NP cells derived from non-degenerate IVDs compared to degenerate (P <0.05); G, further gene
expression analysis performed on this target; P, further protein expression analysis performed on this target.
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CCL8, CXCL1, CXCL3 and CXCL9, are up-regulated in
degenerate samples (Figures 2 and 3).
For thirty cytokine- and chemokine-associated genes
identified by LDA, investigations were extended to incor-
porate 35 cDNA samples across three study groups: non-
degenerate, degenerate and infiltrated. Expression of all
cytokines and chemokines investigated was detected in
all study groups (Figures 4 and 5). In most cases,
expression of cytokine and chemokine receptors were
detected across study groups, with the exceptions of
LIFR, which was only detected within non-degenerate
samples, CXCR2 and CX3CR1, which were only detected
in degenerate and infiltrated samples and CCR2, whichwas not detected in any NP cell sample investigated
(Figures 4 and 5).
To ascertain if differential cytokine and chemokine ex-
pression profiles are associated with IVD degeneration or
are attributable to immune-cell infiltration, comparative
analysis was performed across study groups. Differential
expression profiles were observed in relation to both the
relative level of mRNA expression and frequency at which
mRNA expression was detected. Relative expression levels
of IL-17D, LIF (Figure 4), CCL2, CXCL2 and CX3CL1
(Figure 5) were decreased in degenerate samples com-
pared to non-degenerate (P <0.05 in all cases) while
CXCL8 expression was detected more frequently in de-
generate samples compared to non-degenerate (Figure 5;
Figure 4 (See legend on next page.)
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Figure 4 Cytokine-associated gene expression in nucleus pulposus (NP) cells from non-degenerate, degenerate and infiltrated intervertebral
discs (IVDs). Relative mRNA quantitation of cytokines and receptors was assessed by real-time q-PCR in cDNA samples from non-degenerate,
degenerate and infiltrated study groups. Data shown are detection frequency (ν; pie charts) and relative expression per sample investigated
(scatter plots). N-D, non-degenerate study group; D, degenerate study group; I, infiltrated study group; black star, significant difference in detection
frequency between study groups (P <0.05); black diamond, significant difference in relative expression levels between study groups (P <0.05). LIFR,
leukaemia inhibitory factor receptor.
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between non-degenerate and degenerate study groups
although the relative expression level of IL-6 receptor
(IL-6R) was decreased in degenerate samples, whereas de-
tection frequency of CD4 (IL-16 receptor) was increased
(Figure 4; P <0.05 in both cases).
IL-1β (Figure 4) and CCL3 (Figure 5) expression was
detected more frequently in infiltrated samples compared
to non-degenerate, whereas CX3CL1 was detected less
frequently in infiltrated samples compared to non-dege-
nerate (P <0.05 in all cases). A similar pattern to that seen
in degenerate samples was observed in infiltrated samples
for IL-6R expression (Figure 4), where relative expression
level was decreased compared to non-degenerate samples
(P <0.05). CXC chemokine expression was not signifi-
cantly altered between non-degenerate and infiltrated
samples although detection frequency of receptor CXCR2
was increased in infiltrated samples compared to non-
degenerate (Figure 5; P <0.05).
Comparative analysis was also performed between the
two pathological study groups. Overall, greater cytokine
and chemokine expression was detected in infiltrated
samples compared to degenerate. IL-1β (Figure 4), CCL2
and CCL4 (Figure 5) were detected more frequently in
infiltrated samples and expression levels of IL-6, TNF-α,
TNF-R75, LIF, CCL2, CCL3, CCL5, CXCL1, CXCL2,
CXCL3 and CXCL8 were greater in infiltrated samples
(P <0.05 in all cases).
Quantitation of chemokine production by NP cells in
human NP tissue specimens
To confirm that gene expression translates to protein pro-
duction in vivo, expression of IL-16, CCL2, CCL7 and
CXCL8 in human NP tissue was assessed by IHC. Protein
production was confirmed and localised to native NP cells
(Figure 6A). Although for all targets investigated, expres-
sion was also observed in immune cell infiltrates, where
present, in NP tissue specimens, indicating that NP cells
are not the only source of cytokines and chemokines
within the IVD (Figure 6B). Assessment of percentage cel-
lular immunopositivity localised to NP cells was used to
identify differential expression profiles between study
groups (Figure 7). Protein expression of CCL7 and CXCL8
localised to NP cells was increased in degenerate samples
compared to non-degenerate samples (P <0.05 in both
cases). Protein expression of CCL2 localised to NP cellswas also increased, but not significantly so (P = 0.0526),
in degenerate samples compared to non-degenerate.
Expression of CCL7 and CXCL8 localised to NP cells
was increased in infiltrated samples compared to non-
degenerate (P <0.05 in both cases). Expression of CCL2
localised to NP cells was also increased, but not signifi-
cantly so (P = 0.0870), in infiltrated samples compared to
non-degenerate. IL-16 expression was equivalent across
all study groups.
We then examined if degenerative tissue changes cor-
related with NP cell protein expression of cytokines and
chemokines localised to NP cells, as determined by IHC
(Figure 8). Protein expression of CCL2 and CXCL8 by NP
cells increased concordant to increasing severity of degen-
erative tissue changes in human NP (P = 0.0067 and
P = 0.0067 respectively). Protein expression of CCL7 also
increased concordant to degenerative tissue changes, but
not significantly so (P = 0.0600).
Discussion
In the last decade, our knowledge of cytokine effects
within the IVD has increased substantially, particularly
in respect of IL-1 and TNF-α and the detrimental effects
of elevated levels of these cytokines [12,13,15-19,37,40].
On the contrary, the full extent of cytokine and chemo-
kine production by native IVD cells has not been fully
explored [14,26,36,38]. To the best of our knowledge,
the current study is the first to systematically profile
cytokine and chemokine expression in NP tissue.
In cells isolated from degenerate human tissue we ob-
served an extensive cytokine and chemokine expression
profile. Cytokine and chemokine ligands were detected
in most cases alongside receptors, activating enzymes
and signalling accessory proteins, thus there is the po-
tential for these ligands to act as autocrine or paracrine
factors on the native NP cell population within the IVD.
The effects of IL-1 and TNF-α on NP cell behaviour
have been investigated previously, with both factors eli-
citing effects on cellular metabolism [15,17-19], a param-
eter that is adversely affected in IVD degeneration
[3,9,41]. Notably, it is not only the expression of IL-1 and
TNF-α that is increased in the degenerate IVD [13,15]; the
cellular response to stimulation is altered [15,18], as is the
sensitivity of the cell population, evidenced by altered
expression patterns of the receptors [13,15,16]. Further,
imbalance between IL-1 and its natural inhibitor, IL-1
Figure 5 (See legend on next page.)
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Figure 5 Chemokine-associated gene expression in nucleus pulposus (NP) cells from non-degenerate, degenerate and infiltrated
intervertebral discs (IVDs). Relative mRNA quantitation of chemokines and receptors was assessed by real-time q-PCR in cDNA samples from
non-degenerate, degenerate and infiltrated study groups. Data shown are detection frequency (ν; pie charts) and relative expression per sample
investigated (scatter plots). N-D, non-degenerate study group; D, degenerate study group; I, infiltrated study group; black star, significant
difference in detection frequency between study groups (P <0.05); black diamond, significant difference in relative expression levels between
study groups (P <0.05).
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IVD degeneration in mice [40]. Although IL-1 and TNF-α
are implicated in the pathogenesis of IVD degeneration,
both are expressed at low levels in the normal IVD, indi-
cating a role for these factors under normal physiological
conditions [12,13,15,16].Figure 6 IL-16, CCL2, CCL7 and CXCL8 expression in nucleus pulposu
Representative photomicrographs showing 4-μm paraffin-embedded sectio
IL-16, CCL2, CCL7 and CXCL8 expression was observed in NP cells scattered
represents 100 μm). IL-16, CCL2, CCL7 and CXCL8 expression was also obseAdditional gene expression studies confirmed that the
cytokine- and chemokine-associated gene expression
profile observed in cells from degenerate IVDs was simi-
lar to that from non-degenerate and infiltrated IVDs,
reinforcing the potential of these factors to act as inter-
cellular signalling molecules under normal physiologicals (NP) tissue from prolapsed intervertebral discs (IVDs).
ns of NP tissue stained for IL-16, CCL2, CCL7 and CXCL8 (A). Abundant
throughout tissue sections (original magnification ×400, scale bar
rved in immune cell infiltrates (B).
Figure 7 IL-16, CCL2, CCL7 and CXCL8 expression in non-degenerate, degenerate and infiltrated intervertebral discs (IVDs).
Immunohistochemical quantification of IL-16, CCL2, CCL7 and CXCL8 expression by NP cells in non-degenerate (ND), degenerate (D) and infiltrated
(I) IVDs. Data shown are median values for immunopositivity; black star, significant difference in expression between study groups (P <0.05). IL-16
expression was equivalent across study groups, CCL2, CCL7 and CXCL8 expression was increased in degenerate samples, CCL7 and CXCL8 expression
was also increased in infiltrated samples.
Phillips et al. Arthritis Research & Therapy 2013, 15:R213 Page 12 of 15
http://arthritis-research.com/content/15/6/R213conditions and in the pathologies of IVD degeneration
and prolapse. Although expression of the same factors
was identified, comparative analysis indicated that dif-
ferential expression patterns exist in relation to detec-
tion frequency and relative expression levels. Within the
non-degenerate and degenerate study groups mRNA
detection is assumed to be a result of native NP cell ex-
pression. Interestingly, at the level of mRNA detection,
relative expression of several cytokine and chemokine
ligands; IL-17D, LIF, CCL2, CXCL2 and CX3CL1 was
down-regulated in degeneration. Only CXCL8 mRNA
expression was significantly up-regulated in degenerate
samples compared to non-degenerate counterparts. In
the infiltrated study group, mRNA expression may result
from a combination of NP and infiltrating immune cell
expression. Generally, in infiltrated samples cytokine-
and chemokine-associated gene expression was increased
compared to both non-degenerate and degenerate samples,
particularly so for IL-1β, IL-6, TNF-α, CCL3 [37] and
CXCL8 and this may be due to summated expression by
native NP and infiltrating immune cells.
IHC studies confirmed that a source of cytokine and
chemokine production in the IVD is the native NP cell
population in respect of IL-16, CCL2, CCL7 and CXCL8,
and that production is a feature of NP cells in non-degenerate and pathological IVD tissues. This agrees
with previous reports of NP cell production of IL-1
[15,16], CCL3 and CCL4 [37]. Comparative analysis of
NP cell production in non-degenerate, degenerate and
infiltrated IVDs shows that protein expression of CCL2,
CCL7 and CXCL8 is increased in degenerate and infil-
trated IVDs compared to the non-degenerate coun-
terpart. At the level of NP cell immunopositivity, no
significant differences between degenerate and infiltrated
study groups were observed, whereas previous gene
expression analysis indicated that CCL2 and CXCL8
mRNA expression was greater in infiltrated compared to
degenerate samples. This finding would again point to-
wards infiltrating immune cells as a contributing source
of CCL2 and CXCL8 expression within the IVD, as gene
expression was measured in total cells isolated from tis-
sue specimens, and IHC identified expression of IL-16,
CCL2, CCL7 and CXCL8 in immune cell infiltrates,
although this was not quantified. Of note, upon histo-
logical examination of tissue sections, immune-cell infil-
trates were identified in tissue samples from clinically
reported intact IVDs (protrusion-type prolapse). As
leukocyte infiltration usually occurs following AF or
CEP rupture [27-29,42] and exposure of NP tissue to the
external environment of the IVD [28,43-47], a possible
Figure 8 CCL2, CCL7 and CXCL8 expression correlates with
degenerative tissue changes. Immunohistochemical quantification
of CCL2, CCL7 and CXCL8 expression by nucleus pulposus cells. Data
shown as are immunopositivity values against histologically
determined grade of degeneration. Linear regression analysis was
performed to assess correlation between histologically determined
grade of degeneration and immunopositivity.
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down a radial fissure [4] may come into contact with the
capillary network of the AF [48]. This would provide a
direct route between blood circulation and NP tissue for
circulating leukocyte entry into the intact IVD. Reso-
lution without medical intervention has been described
previously for protrusion-type IVD prolapse, and retraction
of the AF is postulated to mediate this process [24,49].
Based on our observations, leukocyte-mediated break-
down of displaced NP tissue within the intact IVD could
occur and may therefore represent a further mechanism
in the process of protrusion resolution.The context in which we sought to identify the cyto-
kine and chemokine expression profile of the IVD was
in so far as it related to the progression of IVD patho-
logy, and to the effects that it may elicit on attempted
biological therapies targeted at impeding progression of,
or even reversing this pathology. In respect of IVD de-
generation, pathological changes associated with altered
cell behaviour are related to proliferation [5], differen-
tiation [6-8], dysregulated metabolism [3,9] and cell
death [10,11]. It seems reasonable to assume that if the
cytokines and chemokines identified here do form part
of the pathological mechanism of IVD degeneration and
prolapse, their effects would be related to the adverse
alterations in cell behaviour observed in IVD pathology.
Here, we attempted to systematically profile cytokine
and chemokine expression in NP tissue. Initial screening
of cytokine and chemokine gene expression in cells iso-
lated from NP tissue specimens was performed by high
sensitivity real-time q-PCR cDNA LDA. This method
provides advantage over standard PCR detection because
data collection within the exponential phase of amplifi-
cation (prior to reaction saturation) makes this method
fully quantifiable. Data generated therefore provide indi-
cation not just as to the levels of detection frequency in
a study group, but also as to the relative expression
levels within each study group. A limiting factor to this
analysis, however, was the small number of samples sub-
jected to LDA analysis. In light of the small study groups
used, differential expression patterns observed between
non-degenerate and degenerate study groups may not be
representative of those in the wider population. Indeed,
further real-time q-PCR analysis on larger study groups
did not confirm all of the earlier LDA-indicated differen-
tial expression patterns.
Aside of the investigations described previously, the ef-
fects of cytokines and chemokines on NP cell behaviour
have not been comprehensively studied, although their
effects in other cell types have been described. Chondro-
cytes exhibit morphological and biochemical similarity
to NP cells and so the effects of cytokines and chemo-
kines on chondrocyte behaviour may be relevant to that
of NP cells. In chondrocytes, effects of cytokine and che-
mokine stimulation have been described in relation to
all of the common features of altered NP cell behaviour
as seen in IVD degeneration. These include increased
rates of proliferation [50], hypertrophic differentiation
[51,52], increased catabolic metabolism [50,53,54], de-
creased anabolic metabolism [53,54], and induced cell
death [55,56]. The precedents set in these investigations
indicate that further investigative work into the role of
cytokines and chemokines within the IVD is warranted.
Currently, several research initiatives are investigating
the regenerative potential of cell therapy within the IVD
[30-34]. Application of the soluble factor, transforming
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chymal and adipose-derived stem cell differentiation;
indeed, its application in vitro is required to stimulate
differentiation towards an NP phenotype [31,35]. The
survival and differentiation characteristics of stem cells
injected into NP explant cultures, under conditions mo-
delling the environment of the normal IVD have been
confirmed [32]. However, the findings reported here sug-
gest that cells implanted into the degenerate IVD would
encounter a diverse and altered range of soluble factors,
including cytokine and chemokine signalling molecules.
The effects of these on stem cell behaviour have not been
investigated and clearly the response of implanted cells to
their surrounding environment will have considerable
influence over the success of cell therapy to the IVD. To
this end, these investigations provide insight into the con-
ditions of the degenerate niche and indicate that further
investigations to determine the effects this environment
may elicit on cell behaviour are required.
Conclusions
Our data indicate that NP cells are a source of cytokines
and chemokines within the IVD and that these expression
patterns are altered in IVD pathology. These findings may
be important for the correct assessment of the degenerate
niche prior to autologous or allogeneic cell transplantation
for biological therapy of the degenerate IVD.
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